Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis EDITOR,-Borato Viana et al report evidence that malnutrition is an adverse prognostic factor in childhood acute lymphoblastic leukaemia (ALL), suggest that the effect may apply even to moderately undernourished children, and discuss some possible mechanisms.I While the relevance of severe malnutrition to the developed world may seem limited, our own evidence2 indicates that relatively mild undernutrition (weight for height SD score <-0 5) had adverse prognostic significance for children treated for ALL in Glasgow on the UKALL-X protocol. We would also like to add two possible mechanisms which may be worthy of investigation: impairment of immune function by undernutrition and variability in body composition between patients producing variation in drug pharmacokinetics.3
There are now three studies which indicate the need for further research on the relevance of nutritional status to outcome in ALL, and on the possible mechanisms.' 2 4 Central nervous system tumaourslack of national studies EDITOR,-Drs Thome and Foreman, in their letter published in July, point out that children with brain tumours have not been allowed the advantage of participating in national trials because of the lack of such studies and exhort the Medical Research Council (MRC) and UK Children's Cancer Study Group (UKCCSG) to address this issue. ' Their letter unfortunately ignores the. fact that the UKCCSG has been working with the International Society of Paediatric Oncology to run clinical trials for children with primitive neuroectodermal tumours since the mid 1970s. The major problem faced by both the UKCCSG and the International Sociey for Paedia.tric Oncology has been a reluctance by the neurosurgical community, to whomn most of these patients present in the first instance, to pass their clinical care onto paediatric oncologists. Indeed, at a time when 80% of children with malignant disease are being referred to paediatric oncology centres, only 46% of children with central nervous system tumours are being so referred.
The group has recently expanded its area of activities, studies are currently open for the treatment of children with primitive neuroectodermal tumour, brain stem glioma, and for the treatment of infants under the age of 3 years. In the near future, protocols will open for the treatment of children with low and high grade astrocytomas and for intracranial germ cell tumours.
The problem therefore lies not with the efforts of the UKCCSG or the MRC to promote such trials, but with the cooperation that we need to receive from our neurosurgical colleagues, and a willingness from the paediatric oncology community to enter these children to randomised clinical studies. CLIFFORD anomalies.' Three of the children had proved congenital posterior laryngeal clefts, one had subglottic stenosis with a deformed cricoid cartilage, and it is likely that the other two had posterior laryngeal clefts. Although these occurred in only one generation, we speculated that the mode of inheritance may well have been autosomal dominant. We relied primarily on statistical argument that dominant inheritance was more likely as there were only three unaffected children in the two sibships. Five siblings of the mothers had died in infancy and the sixth had stridor all his life which we took as support for the suggested mode of inheritance.
We have now seen the first child of patient 16 (Lyndal) in that report. He was diagnosed at laryngoscopy and bronchoscopy as having a posterior laryngeal cleft which extended down to the circoid cartilage. The father of the child was unrelated to the mother. Patient 14 Judith) has two children, one of whom has laryngomalacia but no cleft. and the other has no symptoms of laryngeal disease. The other affected women have no children.
The occurrence of this malformation in the next generation of the sibships we reported supports our hypothesis that in this family congenital laryngeal clefts are inherited as autosomal dominant trait. PETER Dr Wynne comments: I would agree with Dr Roberton that male circumcision is abusive and will happily support his lead in an education programme to work towards its eradication.
While waiting for his initiative on behalf of men, I will continue to look at the position of women and babies; female genital mutilation doubles the risk of maternal death and increases the risk of the baby being born dead by 3-4 times (World Health Assembly, May 1993).
Circumcision in women involves cutting off the prepuce of the clitoris, with the body of the clitoris remaining intact: this is analogous to male circumcision. Excision refers to cutting off the clitoris with or without the removal of the labia minora. The third type of mutilation, infibulation, involves removal of the clitoris, labia minora and much of the labia majora. The two remaining sides of the vulva are stitched together and a small hole is left inferiorly. There are not surprisingly many complications of infibulation.
The publication Child Protection and Female Genital Mutilation by Hedley and Dorkenoo, published by Forward and endorsed by the Department of Health 1992, explains many of the issues involved and strategies which are likely to be useful. Female genital mutilation describes accurately a procedure which communities (and colleagues) would prefer to refer to euphemistically as female circumcision.
